Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


Drug resistance TB in India: Challenges, issues and solutions

Deepak Saxena, Pankaj Bhardawaj.

Multi Drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are emerging as a major challenges across globe including in India as narrated by the World Health Organization (WHO) for success the Stop TB strategy, launched in 2006.[1] MDR-TB is defined as tuberculosis disease where the bacilli is resistant to isoniazid (H) and rifampicin (R), with or without resistance to other drugs. Irregular consumption and frequent interruption in taking treatment for TB is the most common cause of acquiring multidrug resistance.

Key words: Drug resistance tuberculosis, Multi-drug resistance tuberculosis, Extensively drug resistance tuberculosis

Share this Article

Journal of Contemporary Medical Education


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.